+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fetal Alcohol Syndrome Drugs"

Fetal Alcohol Spectrum Disorder Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fetal Alcohol Spectrum Disorder Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 96 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Fetal Alcohol Syndrome (FAS) Drugs are a type of Central Nervous System (CNS) Drugs used to treat the physical and mental effects of prenatal alcohol exposure. These drugs are used to reduce the severity of physical and mental disabilities caused by FAS, such as facial deformities, growth deficiencies, and cognitive and behavioral problems. FAS Drugs are typically prescribed to pregnant women and infants, and may include medications to treat seizures, anxiety, and depression. FAS Drugs are a relatively new class of CNS Drugs, and research is ongoing to develop more effective treatments. Currently, there are no approved drugs specifically for FAS, but some medications used to treat other CNS conditions may be used off-label to treat FAS. Some companies in the Fetal Alcohol Syndrome Drugs market include Pfizer, GlaxoSmithKline, Merck, and Novartis. Show Less Read more